# EDGAR Filing Document

**Accession Number:** 0001224962
**File Stem:** 0001193125-26-022811
**Filing Date:** 2026-1
**Character Count:** 36588
**Document Hash:** 115f23f5920190116a7d73a5cdec5647
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-022811.hdr.sgml**: 20260126

**ACCESSION NUMBER**: 0001193125-26-022811

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260126

**DATE AS OF CHANGE**: 20260126

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TRINITY BIOTECH PLC
- **CENTRAL INDEX KEY:** 0000888721
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-44122
- **FILM NUMBER:** 26561398

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** IDA BUSINESS PARK
- **STREET 2:** BRAY
- **CITY:** WICKLOW
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 01135312955111

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** IDA BUSINESS PARK
- **STREET 2:** BRAY
- **CITY:** WICKLOW
- **PROVINCE COUNTRY:** L2
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PERCEPTIVE ADVISORS LLC
- **CENTRAL INDEX KEY:** 0001224962

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 51 ASTOR PLACE, 10TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10003
- **BUSINESS PHONE:** 646-205-5300

**MAIL ADDRESS:**
- **STREET 1:** 51 ASTOR PLACE, 10TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10003

## Exhibit 99.1

<u>Schedule A</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;Fund | &nbsp;&nbsp;Date | &nbsp;&nbsp;Transaction | &nbsp;&nbsp;Number of ADSs<sup>(</sup><sup>1</sup><sup>)</sup> | &nbsp;&nbsp;Price |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/23/2025 | &nbsp;&nbsp;Sale<sup>(</sup><sup>2</sup><sup>)</sup> | &nbsp;&nbsp;400000 | &nbsp;&nbsp;$1.64 |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/24/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;680108 | &nbsp;&nbsp;$1.13<sup>(</sup><sup>3</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/26/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;183228 | &nbsp;&nbsp;$1.04<sup>(</sup><sup>4</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/29/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;118686 | &nbsp;&nbsp;$0.83<sup>(</sup><sup>5</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/30/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;61066 | &nbsp;&nbsp;$0.82<sup>(</sup><sup>6</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;12/31/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;7037 | &nbsp;&nbsp;$0.80<sup>(</sup><sup>7</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/02/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;10870 | &nbsp;&nbsp;$0.75<sup>(</sup><sup>8</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/05/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;29411 | &nbsp;&nbsp;$0.76<sup>(</sup><sup>9</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/06/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;30927 | &nbsp;&nbsp;$0.76<sup>(</sup><sup>10</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/07/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;6747 | &nbsp;&nbsp;$0.75<sup>(</sup><sup>11</sup><sup>)</sup> |

---

------

<sup>1</sup> One ADS represents twenty Ordinary Shares.

<sup>2</sup> Covered short sale.

<sup>3</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.35 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>4</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.09 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>5</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.81 to $0.87 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>6</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.81 to $0.84 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>7</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.80 to $0.81 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>8</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.76 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>9</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.78 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>10</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.77 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>11</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.76 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/08/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;20896 | &nbsp;&nbsp;$0.74<sup>(</sup><sup>12</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/09/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;54261 | &nbsp;&nbsp;$0.73<sup>(</sup><sup>13</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/12/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;34155 | &nbsp;&nbsp;$0.73<sup>(</sup><sup>14</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/13/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;10106 | &nbsp;&nbsp;$0.70<sup>(</sup><sup>15</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/14/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;1415 | &nbsp;&nbsp;$0.70<sup>(</sup><sup>16</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/15/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;21799 | &nbsp;&nbsp;$0.71<sup>(</sup><sup>17</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/16/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;5617 | &nbsp;&nbsp;$0.71<sup>(</sup><sup>18</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/20/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;5210 | &nbsp;&nbsp;$0.70 |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/21/2026 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;42059 | &nbsp;&nbsp;$0.70<sup>(</sup><sup>19</sup><sup>)</sup> |
| &nbsp;&nbsp;Perceptive Credit Holdings II, L.P. | &nbsp;&nbsp;01/22/2025 | &nbsp;&nbsp;Sale | &nbsp;&nbsp;66402 | &nbsp;&nbsp;$0.73<sup>(</sup><sup>20</sup><sup>)</sup> |

---

------

<sup>12</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.73 to $0.76 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>13</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.75 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>14</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.75 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>15</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 to $0.72 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>16</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 to $0.71 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>17</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 to $0.73 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>18</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 to $0.71 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>19</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 to $0.71 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

<sup>20</sup> The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.79 inclusive. The reporting persons undertake to provide the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 7)**

**Trinity Biotech plc**

*(Name of Issuer)*

**Class A Ordinary Shares, $0.0001 par value per share**

*(Title of Class of Securities)*

**896438504**

*(CUSIP Number)*

**Alexander Rakitin**<br>Perceptive Advisors LLC<br>51 Astor Place, 10th Floor<br>New York NY 10003<br>(646) 205-5340

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/22/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **896438504** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Perceptive Advisors LLC** | Name of reporting person<br>**Perceptive Advisors LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1463058248.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1463058248.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

**Comment for Reporting Person:** The securities reported on this page consist of securities held directly by Perceptive Credit Holdings II, LP ("Credit Fund II") and Perceptive Credit Holdings III, LP ("Credit Fund III" and, together with Credit Fund II, the "Funds").  The number of Ordinary Shares reported herein consists of (i) 65,000,000 Ordinary Shares issuable upon the exercise of warrants held by the Funds; (ii) 1,165,048,540 Ordinary Shares represented by 58,252,427 American Depositary Shares ("ADSs") issuable upon conversion of the Convertible Note (as defined in Item 4 of the Schedule 13D) held by Credit Fund III; (iii) 97,087,378 Ordinary Shares represented by 4,854,368 ADSs issuable upon conversion of the Milestone Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II; and (iv) 135,922,330 Ordinary Shares represented by 6,796,116 ADSs issuable upon conversion of the Contingent Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II.  The number of ADSs issuable upon conversion of each of the Convertible Note, the Milestone Payment Obligation and the Contingent Payment Obligation reflect a conversion price equal to the Floor Price (as defined in Item 6) of $1.03.  The terms of each of the warrants, the Convertible Note and the Conversion Rights Agreement (as defined in Item 4) restrict the exercise of the warrants and the conversion of the Convertible Note, Milestone Payment Obligation and Contingent Payment Obligation, as applicable, into ADSs to the extent that, upon such exercise or conversion, the number of Ordinary Shares, including the Ordinary Shares underlying ADSs, then beneficially owned by the holder and its Attribution Parties (as defined in the Convertible Note and the Conversion Rights Agreement) would exceed the Beneficial Ownership Cap (as defined in Item 6). Accordingly, notwithstanding the number of Ordinary Shares reported, the Reporting Person disclaims beneficial ownership of any Ordinary Shares, including those underlying ADSs, issuable upon exercise of the warrants, conversion of the Milestone Payment Obligation, conversion of the Contingent Payment Obligation and conversion of the Convertible Note to the extent that upon such exercise or conversion the number of Ordinary Shares beneficially owned by all Reporting Persons hereunder, in the aggregate, would exceed the Beneficial Ownership Cap.

| **CUSIP No.** | **896438504** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Perceptive Credit Advisors LLC** | Name of reporting person<br>**Perceptive Credit Advisors LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1463058248.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1463058248.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

**Comment for Reporting Person:** The securities reported on this page consist of securities held directly by Perceptive Credit Holdings II, LP ("Credit Fund II") and Perceptive Credit Holdings III, LP ("Credit Fund III" and, together with Credit Fund II, the "Funds").  The number of Ordinary Shares reported herein consists of (i) 65,000,000 Ordinary Shares issuable upon the exercise of warrants held by the Funds; (ii) 1,165,048,540 Ordinary Shares represented by 58,252,427 American Depositary Shares ("ADSs") issuable upon conversion of the Convertible Note (as defined in Item 4 of the Schedule 13D) held by Credit Fund III; (iii) 97,087,378 Ordinary Shares represented by 4,854,368 ADSs issuable upon conversion of the Milestone Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II; and (iv) 135,922,330 Ordinary Shares represented by 6,796,116 ADSs issuable upon conversion of the Contingent Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II.  The number of ADSs issuable upon conversion of each of the Convertible Note, the Milestone Payment Obligation and the Contingent Payment Obligation reflect a conversion price equal to the Floor Price (as defined in Item 6) of $1.03.  The terms of each of the warrants, the Convertible Note and the Conversion Rights Agreement (as defined in Item 4) restrict the exercise of the warrants and the conversion of the Convertible Note, Milestone Payment Obligation and Contingent Payment Obligation, as applicable, into ADSs to the extent that, upon such exercise or conversion, the number of Ordinary Shares, including the Ordinary Shares underlying ADSs, then beneficially owned by the holder and its Attribution Parties (as defined in the Convertible Note and the Conversion Rights Agreement) would exceed the Beneficial Ownership Cap (as defined in Item 6). Accordingly, notwithstanding the number of Ordinary Shares reported, the Reporting Person disclaims beneficial ownership of any Ordinary Shares, including those underlying ADSs, issuable upon exercise of the warrants, conversion of the Milestone Payment Obligation, conversion of the Contingent Payment Obligation and conversion of the Convertible Note to the extent that upon such exercise or conversion the number of Ordinary Shares beneficially owned by all Reporting Persons hereunder, in the aggregate, would exceed the Beneficial Ownership Cap.

| **CUSIP No.** | **896438504** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Joseph Edelman** | Name of reporting person<br>**Joseph Edelman** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1463058248.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1463058248.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | Aggregate amount beneficially owned by each reporting person<br>**1463058248.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The securities reported on this page consist of securities held directly by Perceptive Credit Holdings II, LP ("Credit Fund II") and Perceptive Credit Holdings III, LP ("Credit Fund III" and, together with Credit Fund II, the "Funds").  The number of Ordinary Shares reported herein consists of (i) 65,000,000 Ordinary Shares issuable upon the exercise of warrants held by the Funds; (ii) 1,165,048,540 Ordinary Shares represented by 58,252,427 American Depositary Shares ("ADSs") issuable upon conversion of the Convertible Note (as defined in Item 4) held by Credit Fund III; (iii) 97,087,378 Ordinary Shares represented by 4,854,368 ADSs issuable upon conversion of the Milestone Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II; and (iv) 135,922,330 Ordinary Shares represented by 6,796,116 ADSs issuable upon conversion of the Contingent Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II.  The number of ADSs issuable upon conversion of each of the Convertible Note, the Milestone Payment Obligation and the Contingent Payment Obligation reflect a conversion price equal to the Floor Price (as defined in Item 6) of $1.03.  The terms of each of the warrants, the Convertible Note and the Conversion Rights Agreement (as defined in Item 4) restrict the exercise of the warrants and the conversion of the Convertible Note, Milestone Payment Obligation and Contingent Payment Obligation, as applicable, into ADSs to the extent that, upon such exercise or conversion, the number of Ordinary Shares, including the Ordinary Shares underlying ADSs, then beneficially owned by the holder and its Attribution Parties (as defined in the Convertible Note and the Conversion Rights Agreement) would exceed the Beneficial Ownership Cap (as defined in Item 6). Accordingly, notwithstanding the number of Ordinary Shares reported, the Reporting Person disclaims beneficial ownership of any Ordinary Shares, including those underlying ADSs, issuable upon exercise of the warrants, conversion of the Milestone Payment Obligation, conversion of the Contingent Payment Obligation and conversion of the Convertible Note to the extent that upon such exercise or conversion the number of Ordinary Shares beneficially owned by all Reporting Persons hereunder, in the aggregate, would exceed the Beneficial Ownership Cap.

| **CUSIP No.** | **896438504** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Perceptive Credit Holdings II, L.P.** | Name of reporting person<br>**Perceptive Credit Holdings II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**243009708.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**243009708.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**243009708.00** | Aggregate amount beneficially owned by each reporting person<br>**243009708.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** The number of Ordinary Shares reported herein consists of (i) 10,000,000 Ordinary Shares issuable upon the exercise of warrants held by Perceptive Credit Holdings II, LP ("Credit Fund II"), (ii) 97,087,378 Ordinary Shares represented by 4,854,368 American Depositary Shares ("ADSs") issuable upon conversion of the Milestone Payment Obligation (as defined in Item 4 of the Schedule 13D) granted by the Issuer to Credit Fund II and (iii) 135,922,330 Ordinary Shares represented by 6,796,116 ADSs issuable upon conversion of the Contingent Payment Obligation (as defined in Item 4) granted by the Issuer to Credit Fund II. The number of ADSs issuable upon conversion of each of the Milestone Payment Obligation and the Contingent Payment Obligation reflect a conversion price equal to the Floor Price (as defined in Item 6) of $1.03.  The terms of each of the warrants and the Conversion Rights Agreement (as defined in Item 4) restrict the exercise of the warrants and the conversion of the Milestone Payment Obligation and Contingent Payment Obligation, as applicable, into ADSs to the extent that, upon such exercise or conversion, the number of Ordinary Shares, including the Ordinary Shares underlying ADSs, then beneficially owned by the holder and its Attribution Parties (as defined in the Conversion Rights Agreement) would exceed the Beneficial Ownership Cap (as defined in Item 6). Accordingly, notwithstanding the number of Ordinary Shares reported, the Reporting Person disclaims beneficial ownership of any Ordinary Shares, including those underlying ADSs, issuable upon exercise of the warrants, conversion of the Milestone Payment Obligation and conversion of the Contingent Payment Obligation to the extent that upon such exercise or conversion the number of Ordinary Shares beneficially owned by all Reporting Persons hereunder, in the aggregate, would exceed the Beneficial Ownership Cap.

| **CUSIP No.** | **896438504** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Perceptive Credit Holdings III, L.P.** | Name of reporting person<br>**Perceptive Credit Holdings III, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[x] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1220048540.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1220048540.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1220048540.00** | Aggregate amount beneficially owned by each reporting person<br>**1220048540.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** The number of Ordinary Shares reported herein consist of (i) 55,000,000 Ordinary Shares issuable upon the exercise of warrants held by Perceptive Credit Holdings III, LP ("Credit Fund III") and (ii) 1,165,048,540 Ordinary Shares represented by 58,252,427 American Depositary Shares ("ADSs") issuable upon conversion of the Convertible Note (as defined in Item 4 of the Schedule 13D) held by Credit Fund III. The number of ADSs issuable upon conversion of the Convertible Note reflects a conversion price equal to the Floor Price (as defined in Item 6) of $1.03.  The terms of each of the warrants and the Convertible Note restrict the exercise of the warrants and the conversion of the Convertible Note, as applicable, into ADSs to the extent that, upon such exercise or conversion, the number of Ordinary Shares, including the Ordinary Shares underlying ADSs, then beneficially owned by the holder and its Attribution Parties (as defined in the Convertible Note) would exceed the Beneficial Ownership Cap (as defined in Item 6). Accordingly, notwithstanding the number of Ordinary Shares reported, the Reporting Person disclaims beneficial ownership of any Ordinary Shares, including those underlying ADSs, issuable upon exercise of the warrants and conversion of the Convertible Note to the extent that upon such exercise or conversion the number of Ordinary Shares beneficially owned by all Reporting Persons hereunder, in the aggregate, would exceed the Beneficial Ownership Cap.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Ordinary Shares, $0.0001 par value per share

**(b) Name of Issuer:**
Trinity Biotech plc

**(c) Address of Issuer's Principal Executive Offices:**
IDA Business Park, Bray, Co. Wicklow, L2, A98 H5C8

This Amendment No. 7 (this "Amendment No. 7") to Schedule 13D amends the Schedule 13D filed by Perceptive Advisors LLC ("Perceptive Advisors" or "Perceptive"), Perceptive Credit Advisors LLC ("Perceptive Credit Advisors"), Joseph Edelman ("Mr. Edelman"), Perceptive Credit Holdings II, L.P. ("Credit Fund II") and Perceptive Credit Holdings III, L.P. ("Credit Fund III", and together with Perceptive Advisors, Perceptive Credit Advisors, Mr. Edelman and Credit Fund II, each of the foregoing, a "Reporting Person," and collectively, the "Reporting Persons"), as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, and Amendment No. 6 thereto, with respect to the securities of Trinity Biotech plc (such Schedule 13D, as amended, the "Schedule 13D").

**Item 5. Interest in Securities of the Issuer**

**(a)**
Items 5(a)-(c) of the Schedule 13D are amended and supplemented as follows:

The information set forth in the cover pages to this Amendment No. 7 to the Schedule 13D is incorporated by reference. The percentages set forth in row 13 are based on 374,206,640 Ordinary Shares outstanding, as reported in the Issuer's Prospectus filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on January 23, 2026, and assumes the exercise of all Warrants and the conversion of the Convertible Note, the Milestone Payment Obligation and the Contingent Payment Obligation to the extent permitted by the Beneficial Ownership Cap.

**(b)**
The information set forth in Item 5(a) is incorporated herein by reference.

**(c)**
Except as set forth on Schedule A, no Reporting Person has effected any transaction in shares of Ordinary Shares since the filing of Amendment No. 6 to the Schedule 13D, filed with the Securities and Exchange Commission on December 23, 2025.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Perceptive Advisors LLC

**Signature:** /s/ Joseph Edelman

**Name/Title:** Joseph Edelman, Managing Member

**Date:** 01/26/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Perceptive Credit Advisors LLC

**Signature:** /s/ Joseph Edelman

**Name/Title:** Joseph Edelman, Managing Member

**Date:** 01/26/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Joseph Edelman

**Signature:** /s/ Joseph Edelman

**Name/Title:** Joseph Edelman

**Date:** 01/26/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Perceptive Credit Holdings II, L.P.

**Signature:** /s/ Joseph Edelman

**Name/Title:** Joseph Edelman, Managing Member

**Date:** 01/26/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Perceptive Credit Holdings III, L.P.

**Signature:** /s/ Joseph Edelman

**Name/Title:** Joseph Edelman, Managing Member

**Date:** 01/26/2026